The fact that women receive the majority of antibiotic courses for UTI will also dilute the assessment of risk, since women with G6PD deficiency are usually heterozygous, with a phenotypic range of G6PD activity including higher levels than hemizygous males. This evidence concerns the gene G6PD and bacterial urinary tract infection.